Proton therapy market size was $438.33 million in 2021, and is estimated to reach $1.6 billion by 2031, growing at a CAGR of 13.65% from 2022 to 2031. Proton therapy, also known as proton radiotherapy and proton beam therapy, involves radiation devices with protons as a source of radiation. Proton therapy is used to kill cancer cells. In proton therapy particle accelerators are used to target the tumors with a beam of protons. Protons are charged particles that interfere with DNA of cells, thus damaging them leading to cell death. Proton therapy devices are costly, space consuming equipment that comprises accelerators, electro-magnets, gantries, nozzles, and patient rooms.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Major companies profiled in proton therapy industry report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/529
Increase in prevalence of cancer, surge in number of awareness campaigns about benefits of proton therapy, and technological advancements in proton therapy devices are the key proton therapy market trends. In addition, patients are eager to know more about proton therapy treatment process and growth of global recognition of proton therapy and its benefits further drive the market growth. However, high cost of proton therapy and large size of these devices, requiring dedicated areas, are anticipated to hamper the market growth. Conversely, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.
On the basis of indications, the proton therapy market is categorized into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer and others. The central nervous system cancer segment is expected to dominate the market during the forecast period, owing to increase in prevalence of CNS cancer and rise in preference for advance therapies by healthcare professionals.
Depending on product type, the accelerator segment dominated the market in 2021, and is expected to remain dominant during the forecast period, owing to increase in prevalence of cancer, cost advantage as compared to outsourced radioactive tracers and availability of technologically advanced diagnostic devices further boost proton therapy market growth.
On the basis of end user, the hospital segment held the largest proton therapy market share in 2021, and is expected to continue this trend during the forecast period, owing to increase in prevalence of cancer, development in healthcare for infrastructure of hospitals, high tech equipment, and self-awareness about diseases.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/529
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- On the basis of indication, the CNS cancer segment is estimated to register CAGR of 12.41% from 2022 to 2031.
- On the basis of product type, the accelerator segment is estimated to register CAGR of 13.21% from 2022 to 2031.
- By end user, the hospital segment is anticipated to register CAGR of 13.8% from 2022โ2031
- By region, Asia-Pacific is expected grow at the highest CAGR of 14.95% from 2022 to 2031.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com